2022 LUNCH & LEARN Clinical Trials Presentations begins this month with a presentation by Irene Okeke, PharmD, RPh, Senior Science Medical Liaison for Sickle Cell Disease with forma Therapeutics.
Irene Okeke is a Doctor of Pharmacy by training and graduated from the University of New England College of Pharmacy. She completed a 2-year post-doctoral fellowship in the pharmaceutical industry at Merck Oncology in Medical Affairs and went on to become a Medical Science Liaison for 4 years at AbbVie in malignant hematology prior to joining Forma Therapeutics last November. Irene has been close to Sickle Cell Disease her whole life due to having close family members who suffer from this disease and is passionate about learning how best to work with the scientific and CBO communities to bring better access to care for patients.
Join SCTPN and Dr. Okeke for LUNCH & LEARN on Thursday, February 17, at 12 noon. Register on Zoom https://buff.ly/3HaTKyZ.
LUNCH & LEARN serves as a conduit for biotech and pharmaceutical companies to connect with healthcare professionals, health educators, and health advocates.
Sickle Cell Thalassemia Patients Network (SCTPN) is committed to increasing public awareness of sickle cell disease (SCD), improving the quality of life for individuals and families living with with this debilitative condition. LUNCH & LEARN allows medical professionals on the frontline of providing care for the rare disease community to learn about advancements in research to develop innovative disease modifying medications, regenerative and curative therapies.
SCTPN’s objective is to help increase the access to cutting-edge treatment for people living with sickle cell disease and other inherited blood disorders.
To learn more about SCTPN, its programs and services, visit our website at https://sctpn.net .